Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.91B
Enterprise Value3.73B
P/E Ratio-303
PEG Ratio2.85
Price/Sales Ratio4.44
Price/Book Ratio1.22
Enterprise/Revenue4.31
Enterprise/EBITDA3,082.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.02
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue640.18M
Revenue/Share3.18
Gross Profit503.63M
EBITDA219.27M
Net Income18.17M
Diluted EPS0.09

Balance Sheet

Total Cash1.06B
Total Cash/Share5.34
Total Debt564.45M
Total Debt/Equity0.25
Current Ratio3.13
Book Value Per Share11.56

Price History

52-Week Change-33.36
52-Week High23.04
52-Week Low13.75
Moving Average 50 Days16.75
Moving Average 200 Days19.4

Statistics

Average Volume1.82M
Shares Outstanding198.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.27
Trailing Annual Dividend Yield1.91
Payout Ratio-5.28
Last Split Factor13:10
Last Split DateMay 26, 2022
AD